- NSE
- MARKSANS
- BSE
- 524404
- ISIN
- INE750C01026
MARKSANS PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹308.75
+₹5.05 (+1.66%)
NSE close ·
MARKSANS PHARMA closed at ₹308.75 on 9 Nov 2026, up 1.66% on the day, and is up 68.76% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹156.89 to ₹347.60.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹13,991 Cr
- Industry P/E
- 35.5
- Dividend yield
- 0.29%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹866 Cr | ₹159 Cr | — | ₹3.47 |
Armor risk check
MARKSANS PHARMA moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is MARKSANS PHARMA's share price today?
MARKSANS PHARMA (NSE: MARKSANS) closed at ₹308.75 on 9 Nov 2026, up 1.66% from the previous close of ₹303.70. It traded between ₹305.20 and ₹313.50 that day.
What are MARKSANS PHARMA's 52-week high and low?
Over the last 52 weeks MARKSANS PHARMA traded between ₹155.00 and ₹350.95, adjusted for splits and bonuses.
What are MARKSANS PHARMA's NSE symbol, BSE code and ISIN?
MARKSANS PHARMA has NSE symbol MARKSANS, BSE code 524404, ISIN INE750C01026.
How has MARKSANS PHARMA performed over 1, 3 and 5 years?
MARKSANS PHARMA's share price return: 1Y +68.76%, 3Y +35.59% a year, 5Y +35.60% a year. Dividends are not included.
Does MARKSANS PHARMA pay a dividend?
Yes. MARKSANS PHARMA's latest dividend went ex on 20 Aug 2026: Final · ₹0.90 per share. Dividends over the past year come to a yield of 0.29% at the latest close.
What is MARKSANS PHARMA's market cap?
MARKSANS PHARMA's market cap is ₹13,991 Cr at the close on 9 Nov 2026.
Which sector is MARKSANS PHARMA in?
MARKSANS PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how MARKSANS PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app